Advances in Proteasome Enhancement by Small Molecules

Area of Science:

• Molecular Biology
• Neuroscience
• Biochemistry

Background:

• The proteasome system is crucial for degrading misfolded, damaged, and redundant cellular proteins.
• Impaired proteasome function leads to protein accumulation, contributing to age-related and neurodegenerative diseases.
• Neurodegenerative conditions such as Parkinson's, Alzheimer's, and Huntington's diseases are linked to proteasome dysfunction.

Purpose of the Study:

• To review the proteasome's structure and its role in aging and neurodegenerative diseases.
• To explore the potential of enhancing proteasome-mediated protein degradation for therapeutic benefit.
• To summarize compounds that can modulate proteasome activity.

Main Methods:

• Literature review of proteasome structure and function.
• Analysis of the association between proteasome activity and neurodegenerative disease pathogenesis.
• Categorization of small molecules that enhance proteasome-mediated degradation.

Main Results:

• The proteasome's structure facilitates targeted protein degradation.
• Proteasome dysfunction is a common hallmark in aging and neurodegenerative diseases.
• Various small molecules demonstrate potential to enhance proteasome activity.

Conclusions:

• Targeting the proteasome system offers a promising therapeutic avenue for neurodegenerative diseases.
• Modulating proteasome function can help clear disease-associated protein aggregates.
• Further research into proteasome-enhancing compounds is warranted for disease treatment.